The Impact of NK Cell-Based Therapeutics for the Treatment of Lung Cancer for Biologics: Targets and Therapy

Lung cancer has a dismal prognosis and novel targeted therapies leave still room for major improvements and better outcomes. Immunotherapy targeting immune checkpoint (IC) proteins, either as single agents or in combination with chemotherapy, is active but responders constitute only approximately 10...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamilton, Gerhard, Plangger, Adelina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273903/
https://www.ncbi.nlm.nih.gov/pubmed/34262255
http://dx.doi.org/10.2147/BTT.S290305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273903/
https://www.ncbi.nlm.nih.gov/pubmed/34262255
http://dx.doi.org/10.2147/BTT.S290305

Ejemplares similares